SMO Clinplus Co (SZSE:301257) COGS-to-Revenue : 0.75 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co COGS-to-Revenue?

SMO Clinplus Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥137.8 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥184.5 Mil.

SMO Clinplus Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.75.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. SMO Clinplus Co's Gross Margin % for the three months ended in Mar. 2024 was 25.33%.

SMO Clinplus Co COGS-to-Revenue Historical Data

The historical data trend for SMO Clinplus Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co COGS-to-Revenue Chart

SMO Clinplus Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.67

0.71

0.74

0.73

0.70

SMO Clinplus Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.75	0.68	0.66	0.69	0.75

SMO Clinplus Co COGS-to-Revenue Calculation

SMO Clinplus Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	528.941	/	760.043
	=	0.70

SMO Clinplus Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	137.796	/	184.533
	=	0.75

SMO Clinplus Co (SZSE:301257) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

SMO Clinplus Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	137.796 / 184.533
	=	25.33 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

SMO Clinplus Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of SMO Clinplus Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

SMO Clinplus Co (SZSE:301257) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001

Website

http://www.smo-clinplus.com

SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.

Executives

Lai Chun Bao	Director
Ma Lin	Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines